Report of The International Publication Planning Associations 7th Annual Meeting
An in-depth report from the 7th Annual Meeting of the International Publication Planning Association (TIPPA) held in San Francisco, CA, USA, 15-16 June 2009. Written by Elizabeth (Liz) Wager.
Generating and communicating economic and humanistic value to payers and decision makers
Editors’ panel
Senate Finance Committee inquiries
GPP and GPP2
Tackling the authorship debate
Reprints and supplements
Publication and reporting bias
Firewalls: responding to the current regulatory environment
The TIPPA member survey
Conclusions
References
ABOUT THE AUTHOR
Elizabeth (Liz) Wager is the author of books on Getting Research Published: An A to Z of Publication Strategy and How to Survive Peer Review. She is a co-author of Good Publication Practice For Pharmaceutical Companies and the European Medical Writers Association guidelines on the role of medical writers.
After obtaining a first-class zoology degree from Oxford in 1983, she worked for Blackwell Scientific Publications, Janssen-Cilag then Glaxo Wellcome. In 2001, she set up her own company, Sideview, which provides training, writing, editing and publication consultancy services. Since going freelance, Liz has run courses on publication strategy, medical writing and publication ethics on five continents.
She is the Chair of COPE (the Committee on Publication Ethics) and a member of: the BMJ’s Ethics Committee, the World Association of Medical Editors Ethics Committee, and the World Health Organization Scientific Advisory Group on trial registration. She is also a Visiting Fellow at the UK Cochrane Centre.
The reputation of publication planners continues to require defence against accusations of ghost writing and ghost management. Demands for increased transparency remain prevalent, while the age-old issue of industry sponsorship still provokes unwarranted prejudice. Companies are responding positively, with the introduction of new policies on the disclosure of results and an increased focus on compliance. However, this has, in turn, led to a diverse range of guidelines and new challenges for publication planners in interpreting them. The emergence of online communication channels such as blogs, which can often contain misinformation or imbalanced commentary, lends new complications for company communication strategies.
The International Publication Planning Association’s 7th Annual Meeting, covered in depth in this Conference Insights review, looked at the regulatory, ethical and operational challenges in publication planning, and presented an industry in transition. Beginning with an overview of the evolving regulatory frameworks for trial registration and results disclosure, and their impact on publication planning, professionals shared insights into how the industry is responding and what more can be done to enhance its reputation among health professionals and journal editors.
The meeting also explored critical issues such as risk mitigation, budget management and the issues of authorship and developments in health economic and outcomes research from the perspectives of journal editors, publication planning professionals and medical communications experts.
PROGRAMME
Chair: Dan Donovan, President, Envision Pharma, Senior Vice President, United BioSource Corporation
DAY ONE
FDAAA, Efficiency & Accelerated Time Lines: How Does it All Add Up?
Panellists:
Catherine Arnaudeau-Bégard, Lead Manager Publication Planning, Global Medical Affairs, UCB Pharma S.A. Tricia Deja, Manager, Medical Publications, Astellas Pharma Global Development, Inc. Liz Wager, Managing Director, Sideview
Moderator: Maureen F Garrity, Director, Medical Publications, Astellas Pharma Global Development, Inc.
Risk Mitigation in Publication Planning: How to Proactively Face the Industry’s Newest Challenges Dan Donovan, President, Envision Pharma, Senior Vice President, United BioSource Corporation
Doing More with Less: How Publication Planners Can Maintain (& Improve) Fiscal Support from Senior Management Elizabeth Crane, Senior Manager, Medical Publications, Astellas Pharma Global Development, Inc.
Coping with a Global Organization: The Pros & Cons of the Most Popular Models
Panellists:
Mark Molenda, Associate Director, Medical Affairs Strategic Trials Team, Centocor Ortho-Biotech Services LLC Matt Monberg, Senior Scientific Communications Associate, Lilly USA LLC
Moderator: Maureen F Garrity, Director, Publications, Astellas Pharma Global Development, Inc.
The Changing Healthcare Environment: Generating & Communicating Economic & Humanistic Value to Payers & Decision Makers
Christopher Leibman, Senior Director - Pharmacoeconomics, Elan Pharmaceuticals Michael R Pollock, President, Reynolds Pollock & Associates
Clinical Trial Disclosures: Hot Button Issues & the Latest Updates Scott Lassman, Partner, Wilmerhale
The Editors’ Perspective: Promoting a More Effective Partnership between Publication Planners and Journals
Panellists:
Michael Callaham, Editor, Annals of Emergency Medicine Mikel Gray, University of Virginia, Department of Urology and School of Nursing, Editor in Chief, Journal of Wound, Ostomy and Continence Nursing Charon Pierson, Editor-in-Chief, Journal of the Academy of Nurse Practitioners
Moderator: Elizabeth Loder, Clinical Editor (Secondary Care), BMJ
DAY TWO
Senate Finance Program for Medical Publication Professionals
Discussion Leader: Dan Donovan, President, Envision Pharma, Senior Vice President, United BioSource Corporation
What You Need to Know About GPP2: Updates and Implications for Publication Planners
Catherine Arnaudeau-Bégard, Lead Manager Publication Planning, Global Medical Affairs, UCB Pharma S.A. Art Gertel, VP, Strategic Regulatory Consulting, Medical Writing & QA, Beardsworth Consulting Group, Inc. Liz Wager, Managing Director, Sideview
Tackling the Authorship Debate: A Practical Discussion on Disclosure, Transparency & Positive Steps You Can Take to Move Beyond the Guidelines
Panellists:
Nancy Bormann, Associate Director, Medical Communications, Biogen Idec James T Magrann, Publisher, Current Medical Research and Opinion
Moderator:
Kirby Lee, Assistant Professor of Clinical Pharmacy at the School of Pharmacy and Institute of Health Policy Studies, School of Medicine, University of California, San Francisco
Reviews, Reprints & Supplements: Demystifying the Current Environment
Panellists:
Catherine Arnaudeau-Bégard, Lead Manager Publication Planning, Global Medical Affairs, UCB Pharma S.A. Mikel Gray, University of Virginia, Department of Urology and School of Nursing, Editor in Chief, Journal of Wound, Ostomy and Continence Nursing James T Magrann, Publisher, Current Medical Research and Opinion Craig Smith, Senior Editor and Manager, Supplement Division, Elsevier
Moderator:
Elizabeth Crane, Senior Manager, Medical Publications, Astellas Pharma Global Development, Inc.
Publication and Reporting Bias of Clinical Trials Submitted to the FDA
Kirby Lee, Assistant Professor of Clinical Pharmacy at the School of Pharmacy and Institute of Health Policy Studies, School of Medicine, University of California, San Francisco
Firewalls: How do we Reorganize and Conduct Business to Respond to the Current Environment?
Joseph B Laudano, Senior Director, Medical Affairs, Forest Research Institute Ansgar Conrad, Senior Manager, Medical Communications, Actelion Pharmaceuticals US, Inc. Leslie Meltzer, Manager, Medical Communications, Actelion Pharmaceuticals US, Inc.
KeywordPharma publications can be reprinted in bulk on demand. We will be pleased to discuss any branding requirements you have - for example you may wish to include company logos and advertorial. Likewise, individual e-documents can be licensed for multiple-user access, either on web sites or on company intranets. Please contact us.
